A. A. Guneeva
Research Subjects
Research Interests
A. A. Guneeva has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- A. E. Samarin
State Budgetary Healthcare Institution Moscow Multidisciplinary Clinical Center «Kommunarka» of the Moscow Department of Health
1 shared publication - Aleksander G. Talalaev
Morozov Children’s City Clinical Hospital
1 shared publication - Anastasia Vitalievna Kopteva
Pirogov Russian National Research Medical University of the Ministry of Health of Russia. 1 Ostrovityanova St., Moscow, Russia, 117997
1 shared publication - Andrey L. Chernyaev
Fundamental Pulmonology Department Federal Pulmonology Research Institute and Laboratory of Clinical Morphology, A. P. Avtsyn Research Institute of Human Morphology of FSBSI “Petrovsky National Research Centre of Surgery” Moscow Russia
1 shared publication - Andrey Yu. Kruglyakov
Morozovskaya Children’s City Hospital
1 shared publication - Bakhtierdzhon Anvardzhonovich Isoboev
PFUR "Russian Peoples' Friendship University named after Patrice Lumumba. Moscow, Russia
1 shared publication
Latest Publications
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1079-1094
Post-hemorrhagic hydrocephalus in preterm newborns: a literature review (2015-2025)
Introduction. Post — hemorrhagic hydrocephalus (PHH) is a severe complication of intraventricular hemorrhage (IVH) in extremely preterm infants, significantly worsening survival rates and neurodevelopmental outcomes. Objective. To analyze current literature (2015–2025) on the pathogenesis, diagnosis, treatment approaches, and outcomes of PHH in preterm infants. Materials and Methods. This review is based on an analysis of peer — reviewed publications, clinical guidelines, and results of randomized trials addressing PHH. Results. The development of PHH involves a complex interplay of mechanisms: mechanical obstruction of cerebrospinal fluid (CSF) pathways by blood clots, neurotoxic effects of hemoglobin breakdown products and iron, as well as neuroinflammation and meningeal fibrosis. The main diagnostic tool is cranial ultrasonography, which allows assessment of IVH severity and progression of ventriculomegaly; MRI is used as a supplementary method. Treatment options include temporary decompression measures (ventricular taps, reservoirs, subgaleal shunts) and permanent CSF shunting (ventriculoperitoneal shunt). Recently, endoscopic techniques (neuroendoscopic lavage, endoscopic third ventriculostomy with choroid plexus coagulation) have been actively investigated. Despite advances in neonatal care, long — term outcomes remain poor: up to 40–50 % of children develop severe disability, mainly due to periventricular leukomalacia. Conclusion. PHH in preterm infants requires a multidisciplinary approach and early intervention. Prevention of severe IVH remains the cornerstone of prophylaxis. Promising future directions include the development of neuroprotective strategies and the refinement of minimally invasive surgical techniques.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1079-1094
Post-hemorrhagic hydrocephalus in preterm newborns: a literature review (2015-2025)
Introduction. Post — hemorrhagic hydrocephalus (PHH) is a severe complication of intraventricular hemorrhage (IVH) in extremely preterm infants, significantly worsening survival rates and neurodevelopmental outcomes. Objective. To analyze current literature (2015–2025) on the pathogenesis, diagnosis, treatment approaches, and outcomes of PHH in preterm infants. Materials and Methods. This review is based on an analysis of peer — reviewed publications, clinical guidelines, and results of randomized trials addressing PHH. Results. The development of PHH involves a complex interplay of mechanisms: mechanical obstruction of cerebrospinal fluid (CSF) pathways by blood clots, neurotoxic effects of hemoglobin breakdown products and iron, as well as neuroinflammation and meningeal fibrosis. The main diagnostic tool is cranial ultrasonography, which allows assessment of IVH severity and progression of ventriculomegaly; MRI is used as a supplementary method. Treatment options include temporary decompression measures (ventricular taps, reservoirs, subgaleal shunts) and permanent CSF shunting (ventriculoperitoneal shunt). Recently, endoscopic techniques (neuroendoscopic lavage, endoscopic third ventriculostomy with choroid plexus coagulation) have been actively investigated. Despite advances in neonatal care, long — term outcomes remain poor: up to 40–50 % of children develop severe disability, mainly due to periventricular leukomalacia. Conclusion. PHH in preterm infants requires a multidisciplinary approach and early intervention. Prevention of severe IVH remains the cornerstone of prophylaxis. Promising future directions include the development of neuroprotective strategies and the refinement of minimally invasive surgical techniques.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (4)
Difficulties in diagnosing of congenital pulmonary lymphangiectasia (the clinical observation)
Трудности диагностики врожденной лимфангиэктазии легких (клиническое наблюдение)
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (4)
Open AccessDifficulties in diagnosing of congenital pulmonary lymphangiectasia (the clinical observation)
Трудности диагностики врожденной лимфангиэктазии легких (клиническое наблюдение)